Short Interest in CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Grows By 753.2%

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the target of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 133,100 shares, a growth of 753.2% from the November 15th total of 15,600 shares. Based on an average trading volume of 107,300 shares, the short-interest ratio is currently 1.2 days.

CERo Therapeutics Price Performance

NASDAQ:CEROW opened at $0.02 on Friday. CERo Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.25. The company has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.